Related references
Note: Only part of the references are listed.Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials
Matthew P. Goetz et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Communication With Older Patients With Cancer Using Geriatric Assessment A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program
Supriya G. Mohile et al.
JAMA ONCOLOGY (2020)
Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years
Xabier Garcia-Albeniz et al.
ANNALS OF INTERNAL MEDICINE (2020)
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt et al.
LANCET (2020)
Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer
Nina Tamirisa et al.
JAMA ONCOLOGY (2020)
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients
Masataka Sawaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer
Laura Biganzoli et al.
BREAST CANCER RESEARCH (2020)
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review
Lorenzo Rossi et al.
CANCER TREATMENT REVIEWS (2019)
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant et al.
LANCET ONCOLOGY (2019)
The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients
Yanin Chavarri-Guerra et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer
Scott Kizy et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
Hyman B. Muss et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology
Etienne Brain et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis
Lynn J. Howie et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Regional nodal irradiation for early breast cancer; clinical benefit according to risk stratification
Harry Bartelink
BREAST (2019)
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Rafael Caparica et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE
Silvana Leo et al.
ONCOLOGIST (2019)
PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper
Gabor Liposits et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Development and validation of a chemotherapy toxicity (Chemo Tox) risk score for older patients (Pts) with breast cancer (BC) receiving adjuvant/neoadjuvant treatment (Adjuvant Tx): A R01 and BCRF funded prospective multicenter study
A. Hurria et al.
CANCER RESEARCH (2019)
Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
P. J. Larkin et al.
ANNALS OF ONCOLOGY (2018)
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines
P. Bossi et al.
ANNALS OF ONCOLOGY (2018)
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M. Fallon et al.
ANNALS OF ONCOLOGY (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
Supriya G. Mohile et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
Hans Wildiers et al.
LANCET ONCOLOGY (2018)
Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer
Enrique Soto-Perez-de-Celis et al.
LANCET ONCOLOGY (2018)
Palbociclib plus endocrine therapy in older women with HR+/HER2-advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies
Hope S. Rugo et al.
EUROPEAN JOURNAL OF CANCER (2018)
Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
Robert E. Coleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
Nicolo Matteo Luca Battisti et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
Gabe S. Sonke et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Quality indicators in breast cancer care: An update from the EUSOMA working group
Laura Biganzoli et al.
EUROPEAN JOURNAL OF CANCER (2017)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer
Katherine E. Reeder-Hayes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer
Emily J. Guerard et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
Charlotte E. Coles et al.
LANCET (2017)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
David Cameron et al.
LANCET (2017)
Evidence for overuse of medical services around the world
Shannon Brownlee et al.
LANCET (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Surveillance Mammography in Older Patients With Breast Cancer-CanWe Ever Stop?
Rachel A. Freedman et al.
JAMA ONCOLOGY (2017)
Incidence and treatments of DCIS in octogenarians: grade matters
Erin P. Ward et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 US Preventive Services Task Force Recommendation
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2016)
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
J. Klastersky et al.
ANNALS OF ONCOLOGY (2016)
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
G. Jerusalem et al.
ANNALS OF ONCOLOGY (2016)
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
F. Roila et al.
ANNALS OF ONCOLOGY (2016)
Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer
Aron S. Rosenstock et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
N. A. de Glas et al.
BRITISH JOURNAL OF CANCER (2016)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
Vratislav Strnad et al.
LANCET (2016)
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
Barbara Brouwers et al.
ONCOTARGET (2016)
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer A Systematic Review and Meta-analysis
Laura M. Spring et al.
JAMA ONCOLOGY (2016)
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
Abram Recht et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-upaEuro
D. E. Peterson et al.
ANNALS OF ONCOLOGY (2015)
Oncoplastic and reconstructive breast surgery in the elderly
R. James et al.
BRITISH JOURNAL OF SURGERY (2015)
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
R. Coleman et al.
LANCET (2015)
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
Harry Bartelink et al.
LANCET ONCOLOGY (2015)
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Ian H. Kunkler et al.
LANCET ONCOLOGY (2015)
Regional Nodal Irradiation in Early-Stage Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
P. M. Poortmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F. Perrone et al.
ANNALS OF ONCOLOGY (2015)
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
L. Decoster et al.
ANNALS OF ONCOLOGY (2015)
Primary endocrine therapy as a treatment for older women with operable breast cancer - A comparison of randomised controlled trial and cohort study findings
J. L. Morgan et al.
EJSO (2014)
Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer
Carlos H. Barcenas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study
Ines Vaz-Luis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Hans Wildiers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study
Nienke A. de Glas et al.
LANCET ONCOLOGY (2014)
Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study
Nienke A. de Glas et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis
N. A. de Glas et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
Martine Extermann et al.
CANCER (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
Marije E. Hamaker et al.
LANCET ONCOLOGY (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli et al.
LANCET ONCOLOGY (2012)
Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor-Positive Breast Cancer: A TEAM Study Analysis
Willemien van de Water et al.
ONCOLOGIST (2012)
Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
Gabriele Martelli et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer
R. Coleman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
B. M. Syed et al.
BRITISH JOURNAL OF CANCER (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark
Peer Christiansen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The management of cancer pain in the elderly
Damien Urbana et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis
Davide Mauri et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Elucidating the role of chest wall irradiation in 'Intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial
I. H. Kunkler et al.
CLINICAL ONCOLOGY (2008)
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
Hans Wildiers et al.
LANCET ONCOLOGY (2007)
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
Mary C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B experience
Hyman B. Muss et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trastuzumab treatment and the risk of central nervous system (CNS) metastases
M. C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use and outcomes of adjuvant chemotherapy in older women with breast cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort
Elena B. Elkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
D Hind et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
HB Muss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
